Amicus Therapeutics (LTS:0HF9) YoY Rev. per Sh. Growth : 29.10% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Amicus Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Amicus Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was 29.10%.

Amicus Therapeutics's Revenue per Share for the three months ended in Jun. 2024 was $0.42.

Amicus Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Amicus Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicus Therapeutics YoY Rev. per Sh. Growth Chart

Amicus Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

54.38

32.98

11.71

1.15

18.79

Amicus Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															16.61	24.11	25.99	22.97	29.10

Amicus Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Amicus Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(1.353	-	1.139)	/	\| 1.139 \|
=	18.79 %

Amicus Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=	(Revenue per Share (Q: Jun. 2024 )	-	Revenue per Share (Q: Jun. 2023 ))	/	\| Revenue per Share (Q: Jun. 2023 )) \|
=	(0.417	-	0.323)	/	\| 0.323 \|
=	29.10 %

Amicus Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Amicus Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Amicus Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amicus Therapeutics Inc (LTS:0HF9) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

FOLD:USA AM6:Germany AM6:Germany

Address

3675 Market Street, Philadelphia, PA, USA, 19104

Website

https://www.amicusrx.com

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Amicus Therapeutics Headlines

No Headlines